Clinical Trial Update: HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating HX009 plus IN10018 with or without standard chemotherapy for advanced solid tumors, including biliary tract cancer and melan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Melanoma

Drugs mentioned

• HX009
• IN10018

Snippet

Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. | Conditions: Biliary Tract Cancer, Melanoma | Phase 1, Phase 2 | Status: RECRUITING